Arcus Biosciences Net Profit Margin 2017-2021 | RCUS

Arcus Biosciences net profit margin from 2017 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue.
Arcus Biosciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2021-09-30 $0.04B $-0.28B -775.00%
2021-06-30 $0.09B $-0.20B -216.30%
2021-03-31 $0.09B $-0.17B -197.65%
2020-12-31 $0.08B $-0.12B -157.69%
2020-09-30 $0.08B $-0.09B -111.39%
2020-06-30 $0.02B $-0.11B -700.00%
2020-03-31 $0.02B $-0.10B -593.75%
2019-12-31 $0.02B $-0.09B -531.25%
2019-09-30 $0.01B $-0.08B -1000.00%
2019-06-30 $0.01B $-0.07B -690.00%
2019-03-31 $0.01B $-0.06B -611.11%
2018-12-31 $0.01B $-0.05B -625.00%
2018-09-30 $0.01B $-0.05B -728.57%
2018-06-30 $0.00B $-0.06B -2100.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.057B $0.078B
Arcus Biosciences is a biopharmaceutical company. It focused on creating innovative cancer immunotherapies. The company's product portfolio includes AB928, AB122, AB154 and AB680. AB928 which is in its final phase is a potent and selective dual antagonist of the adenosine receptors. AB122 which is in its Phase1 is a monoclonal antibody which potently and selectively blocks a protein called PD-1. AB154 is a monoclonal antibody which potently and selectively blocks a novel immune checkpoint called TIGIT. AB680, which is in its Phase1 is a potent and selective inhibitor of CD73, the enzyme responsible for the extracellular production of adenosine within the tumor micro-environment. Arcus Biosciences is based in Hayward, CA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
QIAGEN (QGEN) Netherlands $10.791B 18.27
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88